|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 91.5 TWD | +0.99% |
|
+2.81% | -13.27% |
PharmaEngine, Inc. reported earnings results for the full year ended December 31, 2022. For the full year, the company reported sales was TWD 654.38 million compared to TWD 654.84 million a year ago. Net income was TWD 318.78 million compared to TWD 426.03 million a year ago.
Basic earnings per share from continuing operations was TWD 2.22 compared to TWD 2.95 a year ago. Diluted earnings per share from continuing operations was TWD 2.22 compared to TWD 2.94 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -13.27% | 403M | |
| +1.51% | 42.75B | |
| +49.22% | 41.61B | |
| +8.57% | 41.34B | |
| -12.36% | 26.59B | |
| +8.92% | 25.49B | |
| -25.13% | 18.12B | |
| +29.17% | 12.24B | |
| -3.12% | 11.76B | |
| +6.35% | 11B |
PHARMAENGINE, INC. 
